Thank You

Thanks for visiting my blog. As a pharmaceutical marketing specialist, I meet more than 300 pharma executives and brand directors each year. Hearing their concerns, challenges, and interests gives me a great perspective on the market and where it's going.

Bookmark this site to keep tabs on what I'm learning from your competitors (no names, I promise!) and your target audience.

Friday, November 14, 2008

Celebrating 62%

Our strategic partner, IMS Health, continues to innovate and expand their offering. We're excited to share the news that their Anonymized Patient-Level Data (APLD) set now captures 62% of all retail pharmacy transactions in the U.S. -- more than any other data company. Previously audited data was at 50%, but now our friends at IMS are clearly in the leadership position. This enhancement brings more clarity to traditional TRx. Don't get me wrong, TRx is great, but as marketers, we appreciate having all of those refills culled from the data. By focusing on the prescriptions in play, we can target those physicians truly in the "buying" process. 

So, I raise my glass (62% full!) and toast IMS. Congratulations, guys! 
Now, how soon can we see 75%?
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)